Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Susie Lee, PharmD (student)

Advertisement

Articles by Susie Lee, PharmD (student)

New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA

BySusie Lee, PharmD (student)
June 14th 2016

Sequirus recently announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent influenza vaccine.

Advertisement

Latest Updated Articles

  • New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA
    New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA

    June 14th 2016



Advertisement
Advertisement

Trending on Contagion Live

1

FDA Approves Ensitrelvir as First Oral Postexposure Prevention Option for COVID-19

2

Aging With HIV: Managing Comorbidities in a Population That Has Outlived Its Prognosis

3

Migration Trends Demonstrate Rare, But Increasing Malaria Cases in New York City

4

Ciprofloxacin, Levofloxacin, and Moxifloxacin: A Clinical Comparison of Fluoroquinolone Safety and Use

5

Post-Exposure Protocol for STDs Prompts Resistant Gonorrhea

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us